Outi Kilpivaara
Outi Kilpivaara
University of Helsinki, Memorial Sloan-Kettering Cancer Center
Verified email at
Cited by
Cited by
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
O Abdel-Wahab, A Mullally, C Hedvat, G Garcia-Manero, J Patel, ...
Blood, The Journal of the American Society of Hematology 114 (1), 144-147, 2009
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer
P Vahteristo, J Bartkova, H Eerola, K Syrjäkoski, S Ojala, O Kilpivaara, ...
The American Journal of Human Genetics 71 (2), 432-438, 2002
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
R Rampal, F Al-Shahrour, O Abdel-Wahab, JP Patel, JP Brunel, ...
Blood, The Journal of the American Society of Hematology 123 (22), e123-e133, 2014
CTCF/cohesin-binding sites are frequently mutated in cancer
R Katainen, K Dave, E Pitkänen, K Palin, T Kivioja, N Välimäki, AE Gylfe, ...
Nature genetics 47 (7), 818-821, 2015
A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
O Kilpivaara, S Mukherjee, AM Schram, M Wadleigh, A Mullally, BL Ebert, ...
Nature genetics 41 (4), 455-459, 2009
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic-or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
A Tefferi, TL Lasho, O Abdel-Wahab, P Guglielmelli, J Patel, ...
Leukemia 24 (7), 1302-1309, 2010
Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
P Koppikar, N Bhagwat, O Kilpivaara, T Manshouri, M Adli, T Hricik, F Liu, ...
Nature 489 (7414), 155-159, 2012
Characterization of uterine leiomyomas by whole-genome sequencing
M Mehine, E Kaasinen, N Mäkinen, R Katainen, K Kämpjärvi, E Pitkänen, ...
New England Journal of Medicine 369 (1), 43-53, 2013
RAD51 135G→ C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies
AC Antoniou, OM Sinilnikova, J Simard, M Léoné, M Dumont, ...
The American Journal of Human Genetics 81 (6), 1186-1200, 2007
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
R Fagerholm, B Hofstetter, J Tommiska, K Aaltonen, R Vrtel, K Syrjäkoski, ...
Nature genetics 40 (7), 844-853, 2008
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
G Jönsson, J Staaf, J Vallon-Christersson, M Ringnér, K Holm, C Hegardt, ...
Breast Cancer Research 12, 1-14, 2010
Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
A Quintás-Cardama, O Abdel-Wahab, T Manshouri, O Kilpivaara, J Cortes, ...
Blood, The Journal of the American Society of Hematology 122 (6), 893-901, 2013
CHEK2 variant I157T may be associated with increased breast cancer risk
O Kilpivaara, P Vahteristo, J Falck, K Syrjäkoski, H Eerola, D Easton, ...
International journal of cancer 111 (4), 543-547, 2004
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science
O Kilpivaara, RL Levine
Leukemia 22 (10), 1813-1817, 2008
Correlation of CHEK2 protein expression and c. 1100delC mutation status with tumor characteristics among unselected breast cancer patients
O Kilpivaara, J Bartkova, H Eerola, K Syrjäkoski, P Vahteristo, J Lukas, ...
International journal of cancer 113 (4), 575-580, 2005
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer
J Tommiska, J Bartkova, M Heinonen, L Hautala, O Kilpivaara, H Eerola, ...
Oncogene 27 (17), 2501-2506, 2008
Prognostic role of HuR in hereditary breast cancer
M Heinonen, R Fagerholm, K Aaltonen, O Kilpivaara, K Aittomäki, ...
Clinical cancer research 13 (23), 6959-6963, 2007
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
K Kämpjärvi, N Mäkinen, O Kilpivaara, J Arola, HR Heinonen, J Böhm, ...
British journal of cancer 107 (10), 1761-1765, 2012
Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer
T Cajuso, UA Hänninen, J Kondelin, AE Gylfe, T Tanskanen, R Katainen, ...
International journal of cancer 135 (3), 611-623, 2014
HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
VH Laitinen, T Wahlfors, L Saaristo, T Rantapero, LM Pelttari, O Kilpivaara, ...
Cancer epidemiology, biomarkers & prevention 22 (3), 452-460, 2013
The system can't perform the operation now. Try again later.
Articles 1–20